Clinical Trial Update: Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy

View source ↗

Summary

Completed clinical trial evaluating effectiveness and handling of Spiolto Respimat in COPD patients conducted in Italy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spio lto Respimat (tiotropium/olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2019-09-30